Avadel Pharmaceuticals (AVDL) EPS (Weighted Average and Diluted): 2009-2020
Historic EPS (Weighted Average and Diluted) for Avadel Pharmaceuticals (AVDL) over the last 11 years, with Dec 2020 value amounting to -$0.22.
- Avadel Pharmaceuticals' EPS (Weighted Average and Diluted) fell 214.29% to -$0.22 in Q4 2020 from the same period last year, while for Dec 2020 it was -$0.40, marking a year-over-year increase of 55.06%. This contributed to the annual value of $0.13 for FY2020, which is 114.61% up from last year.
- Latest data reveals that Avadel Pharmaceuticals reported EPS (Weighted Average and Diluted) of -$0.22 as of Q4 2020, which was down 10.00% from -$0.20 recorded in Q3 2020.
- In the past 5 years, Avadel Pharmaceuticals' EPS (Weighted Average and Diluted) registered a high of $0.68 during Q2 2017, and its lowest value of -$1.71 during Q4 2018.
- Over the past 3 years, Avadel Pharmaceuticals' median EPS (Weighted Average and Diluted) value was -$0.23 (recorded in 2019), while the average stood at -$0.34.
- Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first spiked by 506.67% in 2017, then tumbled by 850.00% in 2018.
- Over the past 5 years, Avadel Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at $0.12 in 2016, then slumped by 250.00% to -$0.18 in 2017, then tumbled by 850.00% to -$1.71 in 2018, then skyrocketed by 95.91% to -$0.07 in 2019, then tumbled by 214.29% to -$0.22 in 2020.
- Its EPS (Weighted Average and Diluted) was -$0.22 in Q4 2020, compared to -$0.20 in Q3 2020 and $0.09 in Q2 2020.